Brain+ establishes UK subsidiary
Copenhagen, Denmark, 17 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
· With the incorporation of Brian+ UK Limited, Brain+ has established legal presence in the UK
· The UK is currently the most mature and attractive market for the company’s software-based dementia therapies
· The establishment of a legal UK entity opens access to
· commercial opportunities in the UK healthcare system, and · funding resources, including UK healthcare grants
· The move is an important step in the execution of Brain+’ UK focused commercial strategyBrain+ A/S (“Brain+” or “